Robalo, Q.; De Mot, L.; Vandromme, M.; Van Goethem, N.; Gabrio, A.; Chung, P.Y.J.; Meurisse, M.; Belgian Collaborative Group on COVID-19 Hospital Surveillance; Catteau, L.; Thijs, C.;
et al. Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study. Vaccines 2023, 11, 14.
https://doi.org/10.3390/vaccines11010014
AMA Style
Robalo Q, De Mot L, Vandromme M, Van Goethem N, Gabrio A, Chung PYJ, Meurisse M, Belgian Collaborative Group on COVID-19 Hospital Surveillance, Catteau L, Thijs C,
et al. Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study. Vaccines. 2023; 11(1):14.
https://doi.org/10.3390/vaccines11010014
Chicago/Turabian Style
Robalo, Queeny, Laurane De Mot, Mathil Vandromme, Nina Van Goethem, Andrea Gabrio, Pui Yan Jenny Chung, Marjan Meurisse, Belgian Collaborative Group on COVID-19 Hospital Surveillance, Lucy Catteau, Carel Thijs,
and et al. 2023. "Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study" Vaccines 11, no. 1: 14.
https://doi.org/10.3390/vaccines11010014
APA Style
Robalo, Q., De Mot, L., Vandromme, M., Van Goethem, N., Gabrio, A., Chung, P. Y. J., Meurisse, M., Belgian Collaborative Group on COVID-19 Hospital Surveillance, Catteau, L., Thijs, C., & Blot, K.
(2023). Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study. Vaccines, 11(1), 14.
https://doi.org/10.3390/vaccines11010014